Every SEC Form 3/4/5 on record for this filer (CIK 1971400) — 2 issuers, 8 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CRVO | CervoMed Inc. | Chief Commercial and Business | 2025-10-08 → 2026-02-13 | 5 | $117,130 |
| INZY | Inozyme Pharma, Inc. | COO | 2023-04-04 → 2025-07-03 | 9 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| CRVO | 2025-11-18 | Buy | 1,500 | $7.95 | $11,925 | 15,000 |
| CRVO | 2025-11-17 | Buy | 3,500 | $8.43 | $29,505 | 13,500 |
| CRVO | 2025-11-14 | Buy | 10,000 | $7.57 | $75,700 | 10,000 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.